Chronic Kidney Diseases, Hypertension
Conditions
Brief summary
This study examines whether a safety-net primary care CKD registry directed at the entire primary care team can enhance the delivery of guideline concordant CKD care, including BP control, ACEi/ARB use and albuminuria quantification.
Interventions
OTHERCKD Registry
Health Service intervention
Sponsors
University of California, San Francisco
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
All PCPs who worked in practice teams and provided longitudinal primary care to patients were eligible to participate in this study. Practice teams that consisted of several physicians (+/- trainees), one nurse, nurse practitioners, medical assistants and behaviorists, were randomized 1:1 to one of two arms with a random number generator: access to an electronic CKD registry or a usual care registry for 12 months.
Exclusion criteria
PCPs who solely provided specialty care, for example HIV services or urgent care, were excluded.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in clinic systolic | 12 months | Change in ambulatory systolic BP measured at ambulatory clinic visits in the health care system. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in proportion of patients with BP control | 12 months | Change in the proportion of patients with BP control defined by BP \<140/\<90 mmHg at an ambulatory clinic visit. |
| Change in proportion fo patients with urine albuminuria quantification | 12 months | Change in proportion of patients whose albuminuria was quantified by a urine test among those had not received quantification at trial initiation. |
| Change in albuminuria severity | 12 months | Change in albuminuria severity (mg urine albumin/g urine creatinine) among those patients with albuminuria quantified at trial initiation |
| Change in proportion of patients with ACEi/ARB prescription | 12 months | Change in proportion of patients prescribed an ACEi/ARB in the clinical record or had a documented reason for no prescription (i.e., allergy, prior development of hyperkalemia, or acute kidney injury) |
Outcome results
None listed